Select Publications
Conference Presentations
2016, 'Perceptions of TasP among HIV-positive gay men with sustained viral suppression', presented at 2016 Australasian HIV & AIDS Conference, Adelaide, 16 November 2016 - 18 November 2016
,2015, 'Parameters associated with adherence to antiretroviral therapy in HIV-infected Australian adults: the PAART study', presented at The Australasian HIV&AIDS Conference, Brisbane, Australia, 16 September 2015 - 18 September 2015
,Conference Abstracts
2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2023, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2023, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: Recruitment to a novel safety and feasibility trial', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2022, '"Sometimes I have a duty of care not to call 000": Reported practices, attitudes and factors influencing consumer responses to GHB overdose', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'An Australian national Prompt Response Network for emerging drugs', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Strengthening first-line support for Australians who use drugs, their friends and families: A training needs analysis for alcohol and other drug helplines for calls relating to methamphetamine and emerging drugs of concern', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209
,2019, 'A rapid clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern in Australia', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
,2019, 'Are we detoxing the right people, in the right setting and in the right way? A rapid review of the literature on withdrawal management', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
,2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
,2019, 'Optimising care for people who inject drugs: A retrospective medical record review of staphylococcus aureus bactaraemia treatment', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
,2019, 'What's in an app? Incorporating an automated consent procedure to recruit those who use methamphetamine to a harm reduction and early intervention smartphone-based application clinical trial', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
,2019, 'CHARACTERISTICS AND TREATMENT OUTCOMES OF THE DRUG TREATMENT POPULATION IN NEW SOUTH WALES: FOCUS ON AMPHETAMINE TYPE STIMULANTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'OPTIMISING CARE FOR PEOPLE WHO INJECT DRUGS: A RETROSPECTIVE MEDICAL RECORD REVIEW OF STAPHYLOCOCCUS AUREUS BACTERAEMIA TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389747500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Reports
2024, NCCRED Clinical Research Funding Program Report 2018 - 2023, http://dx.doi.org/10.26190/unsworks/30272
,2019, Management of withdrawal from alcohol and other drugs, The Sax Institute, http://dx.doi.org/10.57022/mjjp9930, http://dx.doi.org/10.57022/mjjp9930
,2019, Management of withdrawal from alcohol and other drugs: an evidence check rapid review brokered by the Sax Institute for the NSW Ministry of Health, Sax Institute, http://dx.doi.org/10.57022/mjjp9930.
,Theses / Dissertations
2018, Antiretroviral therapy and treatment cascade outcomes in a cohort of adults living with HIV in Australia
,Media
2024, VAN (Video abstract by NCCRED) - Exploring barriers to treatment-seeking with women who use methamphetamine, http://dx.doi.org/10.26190/unsworks/30437
,2024, VAN (Video abstract by NCCRED) - Lisdexamphetamine for the treatment of methamphetamine withdrawal: Safety and feasibility - the OLAM study, http://dx.doi.org/10.26190/unsworks/30443
,2023, VAN (Video abstract by NCCRED) - The health & social characteristics of people who use methamphetamine in New South Wales, http://dx.doi.org/10.26190/unsworks/30637
,2023, VAN (Video abstract by NCCRED) - Strengthening first line telephone support for people who use Methamphetamine, http://dx.doi.org/10.26190/unsworks/30436
,2022, VAN (Video Abstracts by NCCRED) - Pharmacotherapies for Methamphetamine Withdrawal, http://dx.doi.org/10.26190/unsworks/30423
,2022, VAN (Video Abstracts by NCCRED) - The GHB Cultures, Practices and Experiences study, http://dx.doi.org/10.26190/unsworks/30424
,Preprints
2023, Effect of a Smartphone App (S-Check) on Actual and Intended Help-Seeking and Motivation to Change Methamphetamine Use Among Adult Consumers of Methamphetamine in Australia: Randomized Waitlist-Controlled Trial (Preprint), http://dx.doi.org/10.2196/preprints.55663
,2022, “There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia, http://dx.doi.org/10.1101/2022.08.01.22278295
,2020, Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study, http://dx.doi.org/10.21203/rs.3.rs-30957/v1
,